Biomedical, Clinical & Life Sciences

Limit: 1 // PI: N. Halvax ( Family & Community Medicine)

AHCCCS is investing funds from the American Rescue Plan (ARP) into an award program to strengthen Home and Community Based Services (HCBS) in the state. You can find more information on the ARP and Arizona’s spending plans on the AHCCCS ARP Allocations web page.

The ARP Program Awards are intended to enhance the health, safety, and member experience for individuals who receive HCBS. AHCCCS members who can directly benefit include Arizona Long Term Care System (ALTCS) and non-ALTCS members like:

• Individuals who are elderly,
• Individuals with disabilities,
• Individuals living with a Serious Mental Illness (SMI) designation, and
• Children with behavioral health needs.

Eligible HCBS providers can request between $10,000 and $1,000,000 for programmatic or infrastructure projects

 Limit: 1 // H. Ding (Translational Pharmacogenomics)

One nomination will be invited from each of the participating institutions.

The Pew Scholars Program in the Biomedical Sciences provides funding to young investigators of outstanding promise in science relevant to the advancement of human health. The program makes grants to selected academic institutions to support the independent research of outstanding individuals who are in their first few years of their appointment at the assistant professor level. The current grant level is $300,000; $75,000 per year for a four-year period.

Candidates must hold a doctorate in biomedical sciences, medicine, or a related field, including engineering or the physical sciences.

Based on their performance during their education and training, candidates should demonstrate outstanding promise as contributors in science relevant to human health. This program does not fund clinical trials research. Strong proposals will incorporate particularly creative and pioneering approaches to basic, translational, and applied biomedical research. Candidates whose work is based on biomedical principles but who bring in concepts and theories from more diverse fields are encouraged to apply.

Candidates must meet all of the following eligibility requirements:

• Hold a doctorate in biomedical sciences, medicine, or a related field, including engineering or the physical sciences.
• As of Sept. 7, 2024, run an independent lab and hold a full-time appointment at the rank of assistant professor.
• Must not have been appointed as an assistant professor at any institution prior to June 12, 2020, whether or not such an appointment was on a tenure track. Time spent in clinical internships, residencies, in work toward board certification, or on parental leave does not count as part of this four-year limit. Candidates who need an exception on the four-year limit should contact Pew’s program office to ensure that application reviewers are aware an exception has been given.
  • Please note that the eligibility criteria above have been temporarily expanded to account for COVID-related lab shutdowns. Please direct any questions to the program office at scholarsapp@pewtrusts.org.
• May apply to the program a maximum of two times. 
• If applicants have appointments at more than one eligible nominating institution or affiliate, they may not reapply in a subsequent year from a different nominating entity.
• May not be nominated for the Pew Scholars Program and the Pew-Stewart Scholars Program for Cancer Research in the same year.

No Applicants // Limit: 1 // Tickets Available: 1

Only one application per institution (normally identified by having a unique UEI or NIH IPF number) is allowed.

This notice of funding opportunity (NOFO) invites applications from clinical investigators to participate in the National Drug Abuse Treatment Clinical Trials Network (CTN) and contribute to the network's capacity torespond to urgent public health needs. The National Institute on Drug Abuse (NIDA) intends to continue to develop and test interventions for addressing the wide spectrum of substance use problems via collaborative partnerships among NIDA, clinical research investigators, community representatives, healthcare providers, and healthcare institutions.  

This NOFO requires a Plan for Enhancing Diverse Perspectives (PEDP), which will be assessed as part of the scientific and technical peer review evaluation. Applications that fail to include a PEDP will be considered incomplete and will be withdrawn. Applicants are strongly encouraged to read the NOFO instructions carefully and view the available PEDP guidance material. Application budgets are limited to $500,000 per year in direct costs. Facilities and administrative costs requested by consortium participants are not included in the direct cost limitation.The maximum project period is seven years. 

No applicats  // Limit: 1 // Tickets Available: 1

DOL will consider only one application from each organization.

Under this Funding Opportunity Announcement (FOA), DOL will award grants through a competitive process to organizations providing pre-apprenticeship services that support education, occupational skills training, and employment services to opportunity youth, ages 16 to 24, while performing meaningful work and service to their communities. The YouthBuild program model prepares participants for quality jobs in a variety of careers, in diverse industry sectors, particularly in infrastructure sectors, and includes wrap-around services such as mentoring, trauma-informed care, personal counseling, transportation supports, and employment preparation - all key strategies for addressing violence in communities. YouthBuild applicants must include construction skills training and may include occupational skills training in other indemand industries. This expansion into additional in-demand industries is the Construction Plus component 

No applicants   // Limit: 1 // Tickets Available: 1 

Only one application per institution (normally identified by having a unique NIH Institutional Profile Number, IPF) is allowed.

The goal of the Medical Scientist Training Program (MSTP) is to develop a diverse pool of highly trained clinician-scientist leaders available to meet the Nation’s biomedical research needs. Specifically, this fundingopportunity announcement (FOA) provides support to eligible domestic institutions to develop and implement effective, evidence-informed approaches to integrated dual-degree training leading to the award of both clinical degrees, e.g., M.D., D.O., D.V.M., D.D.S., Pharm.D., and research doctorate degrees (Ph.D.). With the dual qualification of rigorous scientific research and clinical practice, graduates will be equipped with the skills to develop research programs that accelerate the translation of research advances to the understanding, detection, treatment and prevention of human disease, and to lead the advancement of biomedical research. Areas of particular importance to NIGMS are the iterative optimization of MSTP training efficacy and efficiency, fostering the persistence of MSTP alumni in research careers, and enhancing the diversity of the clinician-scientist workforce. NIGMS expects that the proposed research training programs will incorporate didactic, research, mentoring and career development elements to prepare trainees for careers that will have a significant impact on the health-related research needs of the Nation.
 

No applicants // Limit: 1 // Tickets Available: 1

HRSA will only review the last validated application before the Grants.gov due date.

The Health Resources and Services Administration (HRSA) HIV/AIDS Bureau (HAB) is accepting applications for the fiscal year (FY) 2024 Ryan White HIV/AIDS Program (RWHAP) Implementation for HIV Clinical QualityImprovement program. The purpose of this program is to provide RWHAP Part A through D recipients with training and technical assistance (T/TA) to implement quality improvement methodologies and concepts with an emphasis on skills development and implementing sustainable quality improvement activities for RWHAP Part A through D recipients with little or no experience in quality improvement. The activities outlined in this Notice of Funding Opportunity (NOFO) align with the Ryan White HIV/AIDS Program statute and HRSA HAB Clinical Quality Management (CQM) Policy Clarification Notice 15-02 (PCN 15-02). Specifically, PCN 15-02 clarifies that CQM programs consist of three components: infrastructure, performance measurement, and quality improvement. This cooperative agreement will address the quality improvement component. 

No applicants // Limit: 1 // Tickets Available: 1

Only one application per institution (normally identified by its UEI number) is allowed.

The purpose of this NOFO is to support comparative effectiveness trials to investigate the feasibility, effectiveness, and cost-effectiveness of telehealth-based interventions to detect and manage glaucoma among high-risk populations. This NOFO aims to support the study of replicable and scalable interventions that use real-world, payer-provider reimbursement structures within community-based, health care delivery settings in various regions of the United States. Outcomes should be relevant to clinical practice, public health, community implementation, and policy. This NOFO also supports the cost-effectiveness analyses of proposed interventions. The resulting data will assist policymakers, clinicians, and patients make informed decisions to reduce the burden of glaucoma and improve the quality of life for millions of people.

This NOFO will be accomplished through two components, Component A: Comparative effectiveness trials among high-risk populations within community-based settings, and Component B: a coordinating center to provide scientific and logistical support to Component A studies. 

Component A: Number of Awards: four (4); Estimated Funding: $2,750,000
Component B: Coordinating Center Number of Awards: One (1); Estimated Funding: $250,000

No Applicants // Limit: 1 // Tickets Available: 1

Only one application per institution (normally identified by having a unique entity identifier [UEI] number) is allowed. 

This Notice of Funding Opportunity (NOFO) is designed to understand the feasibility and acceptability of providing long-acting injectable antiretroviral therapy (LAI-ART) to incarcerated persons with HIV who are soon to be released from state prison facilities. The ultimate goal is to support the development and implementation of effective, sustainable, replicable LAI-ART programs. People with HIV living in prison facilities are often released to the community lacking support for ongoing HIV care. There is a paucity of programs for this population demonstrating effectiveness with retention in care and maintaining sustained HIV viral suppression after release. The use of LAI-ART prior to and at the time of release from prison may improve adherence to HIV treatment, retention in care, and maintenance of viral load suppression among persons reentering the community. Applied qualitative and quantitative research resulting from this funding is expected to strengthen adherence to ART and is aligned with the HIV National Strategic Plan (2022-2025) and the Ending the HIV Epidemic in the U.S. (EHE) initiative “Treat” Pillar.

Limit: 2 // Tickets Available: 1

 H-J. Kim (Civil Engineering)

Institutions can receive only two awards each year and can submit a limit of two applications per year.
*The ORAU Innovation Partnerships Grant Program is a single fiscal year award for events held between September 1, 2023 and September 30, 2024.

Event or conference sponsorship is often beneficial to the Oak Ridge Associated Universities (ORAU) Council of Sponsoring Institution Members, whether as a means of fostering collaboration among Council members, gaining new and important information for a proposal or business plan, and more. Up to $4,000 may be requested to support an in-person or virtual event that involves participants from more than one ORAU member institution, including students. Innovation Partnership applications should focus on focused workshops/conferences that highlight your university’s strategic STEM research and education growth areas, and where collaborations with other member universities would add value. We are specifically interested in events that can bring more thought leadership in building a national strategy for STEM education and workforce development. Member universities are encouraged to collaborate around this topic in anticipation of federal funding initiatives. 

FY 2024 Innovation Partnerships Grant Focus Areas:

• Climate and Environment - sustainability, environmental justice, clean energy, resilience to climate hazards, emerging technologies, measurement and impact assessment, diversity and inclusion, policy, and data science and analytics
• Health Equity - telemedicine, telehealth, health literacy, health communication, behavioral and mental health, health disparities, diversity and inclusion, policy, and data science and analytics
• Future of the STEM Workforce - new ways of teaching and learning (K-16), transformative workforce capacity building and mentoring, diversity and inclusion, policy, data science, machine learning, and artificial intelligence

No Applicants  // Limit:1  // Tickets Available: 1

No pre-proposals were received in the internal competition.

The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The overarching goal of this R25 program is to support educational activities that encourage individuals from diverse backgrounds, including those from groups underrepresented in the biomedical and behavioral sciences, to pursue further studies or careers in research. 

To accomplish the stated over-arching goal, this NOFO will support educational activities with a primary focus on: 

• Courses for Skills Development
• Research Experiences
• Mentoring Activities